| Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters KJ Cheung, V Padmanaban, V Silvestri, K Schipper, JD Cohen, ... Proceedings of the National Academy of Sciences 113 (7), E854-E863, 2016 | 402 | 2016 |
| BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants F Elstrodt, A Hollestelle, JHA Nagel, M Gorin, M Wasielewski, ... Cancer research 66 (1), 41-45, 2006 | 249 | 2006 |
| Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry PM Pierorazio, MH Johnson, MW Ball, MA Gorin, BJ Trock, P Chang, ... European urology 68 (3), 408-415, 2015 | 225 | 2015 |
| Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations JJ Tosoian, MA Gorin, AE Ross, KJ Pienta, PT Tran, EM Schaeffer Nature Reviews Urology 14 (1), 15, 2017 | 152 | 2017 |
| Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging S Sheikhbahaei, A Afshar-Oromieh, M Eiber, LB Solnes, MS Javadi, ... European journal of nuclear medicine and molecular imaging 44 (12), 2117-2136, 2017 | 144 | 2017 |
| Protein kinase Cε: an oncogene and emerging tumor biomarker MA Gorin, Q Pan Molecular cancer 8 (1), 1-8, 2009 | 143 | 2009 |
| PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges SP Rowe, MA Gorin, ME Allaf, KJ Pienta, PT Tran, MG Pomper, AE Ross, ... Prostate cancer and prostatic diseases 19 (3), 223-230, 2016 | 116 | 2016 |
| Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 113 | 2020 |
| Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind) A Khalifeh, JH Kaouk, S Bhayani, C Rogers, M Stifelman, YS Tanagho, ... The Journal of urology 190 (5), 1674-1679, 2013 | 109 | 2013 |
| Grade heterogeneity in small renal masses: potential implications for renal mass biopsy MW Ball, SM Bezerra, MA Gorin, M Cowan, CP Pavlovich, PM Pierorazio, ... The Journal of urology 193 (1), 36-40, 2015 | 100 | 2015 |
| Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18 F-DCFPyL PET/CT SP Rowe, MA Gorin, HJ Hammers, MS Javadi, H Hawasli, Z Szabo, ... Annals of nuclear medicine 29 (10), 877-882, 2015 | 97 | 2015 |
| Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors MA Gorin, SP Rowe, AS Baras, LB Solnes, MW Ball, PM Pierorazio, ... European urology 69 (3), 413-416, 2016 | 86 | 2016 |
| Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis MA Gorin, MW Ball, PM Pierorazio, YS Tanagho, SB Bhayani, JH Kaouk, ... The Journal of urology 190 (5), 1907-1911, 2013 | 85 | 2013 |
| Pomegranate fruit extract impairs invasion and motility in human breast cancer GN Khan, MA Gorin, D Rosenthal, Q Pan, LW Bao, ZF Wu, RA Newman, ... Integrative cancer therapies 8 (3), 242-253, 2009 | 84 | 2009 |
| Development of an automated and sensitive microfluidic device for capturing and characterizing circulating tumor cells (CTCs) from clinical blood samples P Gogoi, S Sepehri, Y Zhou, MA Gorin, C Paolillo, E Capoluongo, ... PloS one 11 (1), e0147400, 2016 | 72 | 2016 |
| Factors that influence patient enrollment in active surveillance for low-risk prostate cancer MA Gorin, CT Soloway, A Eldefrawy, MS Soloway Urology 77 (3), 588-591, 2011 | 72 | 2011 |
| Safety and early oncologic effectiveness of primary robotic retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer SM Pearce, S Golan, MA Gorin, AN Luckenbaugh, SB Williams, JF Ward, ... European urology 71 (3), 476-482, 2017 | 70 | 2017 |
| Proposal for a structured reporting system for prostate-specific membrane antigen–targeted PET imaging: PSMA-RADS version 1.0 SP Rowe, KJ Pienta, MG Pomper, MA Gorin Journal of Nuclear Medicine 59 (3), 479-485, 2018 | 69 | 2018 |
| A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE) N Radwan, R Phillips, A Ross, SP Rowe, MA Gorin, ES Antonarakis, ... BMC cancer 17 (1), 1-9, 2017 | 69 | 2017 |
| Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk … MA Gorin, SP Rowe, HD Patel, I Vidal, M Mana-Ay, MS Javadi, LB Solnes, ... The Journal of urology 199 (1), 126-132, 2018 | 68 | 2018 |
